UNITAID Tuberculosis 22 March 2021

Various shots, patients waiting at the Highfield Polyclinic, Harare, ZIMBABWE
SOUNDBITE (English) Robert Matiru, Director of Programmes at Unitaid: “Despite being preventable and curable, tuberculosis is one of the deadliest infections in the world killing 1.5 million people each year. 10 million people fall ill with tuberculosis each year as well and many of them are children almost 900 000 and mostly in low and middle-income countries and some of the poorest countries in the world. It’s also the leading killer of people living with HIV. About a quarter of the world’s population, roughly 1.7 billion people are infected with TB, the latent form. However, if this is not treated with preventive measures and therapies it can become active and people will become sick and die. To make matters worse, COVID-19 has exacerbated the problem and set many national programs back in their efforts to respond to the TB pandemic in their countries.”
Various shots, Jakarta, INDONESIA, Irma Rosita, pharmacist at the Puskemas Senen, preparing and giving tuberculosis preventive therapy drugs to a patient.
SOUNDBITE (Bahasa Indonesia) Patih Natawijaya, patient at the Kramat Pulo Health Center: “At first I did not know what preventive therapy was. I was advised by the healthcare workers from Puskemas Kecamatan Senen to start on TB preventive treatment because my mother in law who currently lives with us has pulmonary tuberculosis. The healthcare workers explained to me that my wife, my children were household contacts and could potentially be infected by tuberculosis. I was explained the importance of taking preventive treatment to prevent the germs from developing in active TB”.
SOUNDBITE (English) Robert Matiru, Director of Programmes at Unitaid: “If we are going to have any chance of ending TB in the next ten to twelve years, we have to prevent it in the first place. Unitaid has been at the forefront working with many partners, governments, manufacturers, civil society, activists and the WHO to bring a new treatment to prevent TB : 3HP. We are combining two treatments into one which reduces how many pills someone has to take a day from 9 to 3. It is easier to do this, it reduces the logistics and packaging and we have also lowered to the cost by almost 70% for this treatment which is very important”.
Med shots, nurses at Highfield Polyclinic in Harare, ZIMBABWE reading leaflets
SOUNDBITE (English) Nurse at Highfield Polyclinic in Harare: “Our clients are complementing 3HP. Since it’s a shorter course, most of them are embracing 3HP. They say it is well tolerated than INH. INH is a six months course but for 3HP it is only taken once weekly so pill burden is lesser. So, most of our clients they are appreciating 3HP over other preventive therapies. And also our clients are reporting less side effects”.
Exterior view of the Malhangalene Health Center, Maputo, MOZAMBIQUE
Various shots : interior views of the Malhangalene Health Center, Maputo, patient consulting a doctor with a baby in her arms
SOUNDBITE (English) Ivan Manhiça, National TB Control Program Director at the Ministry of Health, Maputo: “Tuberculosis is one of the three main causes of death in Mozambique. It is a disease that causes long death. It can also prevent people from going to work and so even if it can be cured, it is better to prevent it than to treat it. Prevention is being implemented at national level. Three types of medicines have been approved in the country among which isoniazid that we have used for a long time. But also now since 2020 we have approved the 3HP that we are starting to introduce in the country next week and gradually in all the country”.

UNITAID Tuberculosis 22 March 2021

Similar Stories